News for Masimo Corporation (MASI)

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential violations of federal and state l

Masimo (MASI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

[url="]Masimo[/url] (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on T

Masimo Corporation (NASDAQ:MASI) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsEli Kammerman - Vice President, Business...

The following slide deck was published by Masimo Corporation in conjunction with their 2024 Q4 earnings call.

Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.

Masimo (MASI) Q4 earnings out Feb 25! Consensus EPS: $1.43 (+14.4% Y/Y), Revenue: $593.35M (+8.1% Y/Y).

Besides Wall Street's top -and-bottom-line estimates for Masimo (MASI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

In the current market session, Masimo Inc. MASI stock price is at $179.97, after a 0.22% drop. However, over the past month, the company's stock increased by 5....

**media[539927]**

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Does Masimo (MASI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Today the Board of Directors (the ”œBoard”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the

MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28, 2024 and provide

[url="]The Law Offices of Frank R. Cruz[/url] is investigating potential claims against the board of directors of Masimo Corporation (”œMasimo” or the ”œCo

Wells Fargo publishes 9 high-conviction & catalyst-driven long/short ideas for Q1

The wearable healthcare devices market is anticipated to reach USD XXX.X million by 2030 from USD XXX.X million in 2022, at a CAGR of 13.1% during the forecast period. Devices worn on the body to…